BioAtla (BCAB) Non-Current Assets (2020 - 2026)
BioAtla's Non-Current Assets was $5.25 million in Q2 2026, down 19.5% from $6.52 million a year earlier and down 4.1% from the prior quarter.
Powered by 
Analysis
BioAtla (BCAB) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at BioAtla came in at $5.82 million, up 388.7% from FY2024.
- Non-Current Assets shows a five-year compound annual growth rate of 6.4% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $1.19 million in FY2024 (-63.4%), $3.25 million in FY2023 (-38.7%), $5.31 million in FY2022 (-25.6%) and $7.13 million in FY2021 (+67.5%).
- The Q2 2026 figure marks the lowest quarterly Non-Current Assets since Q1 2025.
- Compared with a year earlier, Non-Current Assets was higher in four of the last eight quarters, with growth averaging 160.1%.
- The best year-over-year quarter for Non-Current Assets over five years was Q1 2026 (growth of 626.8%); the worst was Q1 2025 (a decline of 72.8%).
- Per Business Quant data, BCAB's Non-Current Assets in the three quarters before Q2 2026 was $5.47 million (Q1 2026), $5.82 million (Q4 2025) and $6.24 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 14.88 Bn |
| 10 | BioAtla | 2.49 Mn | 2.49 Mn | - | 5.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.25 Mn |
| Mar 31, 2026 | 5.47 Mn |
| Dec 31, 2025 | 5.82 Mn |
| Sep 30, 2025 | 6.24 Mn |
| Jun 30, 2025 | 6.52 Mn |
| Mar 31, 2025 | 753,000.00 |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Mar 31, 2024 | 2.77 Mn |
| Dec 31, 2023 | 3.25 Mn |
| Sep 30, 2023 | 3.85 Mn |
| Jun 30, 2023 | 4.33 Mn |
| Mar 31, 2023 | 4.84 Mn |
| Dec 31, 2022 | 5.31 Mn |
| Sep 30, 2022 | 5.80 Mn |
| Jun 30, 2022 | 6.30 Mn |
| Mar 31, 2022 | 6.63 Mn |
| Dec 31, 2021 | 7.13 Mn |
| Sep 30, 2021 | 4.06 Mn |
API Access
BioAtla Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=BCAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "BCAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=BCAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();